Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibroblast growth factor 6 (FGF6) is a member of the fibroblast growth factor family, acting as a cytokine and growth factor with key roles in cell proliferation, survival, and differentiation, especially in skeletal muscle regeneration and myogenic lineage commitment[1][2][5]. FGF6 is primarily expressed in muscle tissue, where it promotes expansion of muscle satellite cells and enhances regenerative potential, but it also has important systemic effects, such as modulating adipocyte thermogenesis and influencing bone remodeling by stimulating both osteoblast and osteoclast activity[2]. Dysregulation or aberrant expression of FGF6 is associated with tumorigenesis (notably in bladder cancer and hematologic malignancies), altered energy metabolism, and impaired tissue repair. FGF6 acts through binding and activating specific FGF receptors (FGFRs), resulting in complex downstream signaling that balances proliferation, differentiation, and tissue-specific functions[1][5][2].
Activation or modulation of fibroblast growth factor receptors (FGFRs), leading to downstream mitogenic, cell survival, and differentiation signaling pathways in responsive cells[5][2][1]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibroblast growth factor 6 (FGF6).